CBHcy is a dual-substrate analogue, a specific BHMT inhibitor that causes betaine-homocysteine S-methyltransferase (BHMT) to adopt the same conformation as the ternary complex, potentially inducing the development of cysteinemia.
Molecular Weight:
235.3
Purity:
>99.99%
CAS Number:
[88096-02-0]
Formula:
C9H17NO4S
Target:
Transferase|||DNA Methyltransferase
T25210
* VAT and and shipping costs not included. Errors and price changes excepted
